J. Sridevi

发表

Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.

P. Yogeeswari, D. Sriram, S. Kantevari, 2016, Bioorganic & medicinal chemistry letters.

N-Arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: design, new methods of synthesis and biological evaluation

R. Bansal, P. Yogeeswari, D. Sriram, 2014 .

Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.

P. Yogeeswari, D. Sriram, Ganesh Samala, 2014, European journal of medicinal chemistry.

New class of antitubercular compounds: synthesis and anti-tubercular activity of 4-substituted pyrrolo[2,3-c]quinolines

P. Yogeeswari, D. Sriram, M. Akula, 2014, Monatshefte für Chemie - Chemical Monthly.

Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.

P. Yogeeswari, D. Sriram, S. Kantevari, 2014, European journal of medicinal chemistry.

Design, synthesis and antitubercular evaluation of novel 2-substituted-3H-benzofuro benzofurans via palladium-copper catalysed Sonagashira coupling reaction.

P. Yogeeswari, S. Kantevari, Thirumal Yempala, 2013, Bioorganic & medicinal chemistry letters.

General and efficient synthesis of benzoxazol-2(3H)-ones: evolution of their anti-cancer and anti-mycobacterial activities

P. Yogeeswari, D. Sriram, V. Vijayakumar, 2014 .

Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.

T. N. Guru Row, P. Yogeeswari, D. Sriram, 2015, European journal of medicinal chemistry.

Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.

P. Yogeeswari, D. Sriram, Shalini Saxena, 2014, Bioorganic & medicinal chemistry.

Discovery and Structure Optimization of a Series of Isatin Derivatives as Mycobacterium tuberculosis Chorismate Mutase Inhibitors

P. Yogeeswari, D. Sriram, Reshma Alokam, 2014, Chemical biology & drug design.

Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities

P. Yogeeswari, D. Sriram, Shalini Saxena, 2015, Molecular informatics.

Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.

P. Yogeeswari, D. Sriram, Shalini Saxena, 2014, Bioorganic & medicinal chemistry.

Identification and structure–activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors

P. Yogeeswari, D. Sriram, Reshma Alokam, 2014, Journal of enzyme inhibition and medicinal chemistry.

Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling.

P. Yogeeswari, D. Sriram, P. Kulkarni, 2015, Organic & biomolecular chemistry.

Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.

P. Yogeeswari, D. Sriram, Dinesh Kumar, 2016, Bioorganic & medicinal chemistry letters.

Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitors.

P. Yogeeswari, D. Sriram, P. Kulkarni, 2015, Bioorganic & medicinal chemistry.

Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors.

P. Yogeeswari, D. Sriram, P. Kulkarni, 2015, Bioorganic & medicinal chemistry.

Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.

P. Yogeeswari, D. Sriram, J. Renuka, 2013, European journal of medicinal chemistry.

Structure‐Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors

P. Yogeeswari, D. Sriram, Shalini Saxena, 2014, ChemMedChem.

Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.

P. Yogeeswari, D. Sriram, Kalaga Mahalakshmi Naidu, 2013, Bioorganic & medicinal chemistry letters.

Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors.

P. Yogeeswari, D. Sriram, Shalini Saxena, 2015, European journal of medicinal chemistry.

Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.

P. Yogeeswari, D. Sriram, J. Renuka, 2015, International journal of mycobacteriology.

Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.

P. Yogeeswari, D. Sriram, A. Kamal, 2015, Bioorganic & medicinal chemistry letters.

Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.

P. Yogeeswari, D. Sriram, Shalini Saxena, 2015, Bioorganic & medicinal chemistry.

4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.

P. Yogeeswari, D. Sriram, J. Renuka, 2015, European journal of medicinal chemistry.

An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.

P. Yogeeswari, D. Sriram, J. Renuka, 2014, Bioorganic & medicinal chemistry.

Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.

P. Yogeeswari, D. Sriram, J. Renuka, 2014, Bioorganic & medicinal chemistry.

Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies.

D. Sriram, P. Shah, A. Chakraborti, 2016, European journal of medicinal chemistry.

Extending the N-linked aminopiperidine class to the mycobacterial gyrase domain: pharmacophore mapping from known antibacterial leads.

P. Yogeeswari, D. Sriram, J. Renuka, 2014, European journal of medicinal chemistry.

Synthesis and antitubercular evaluation of 2-iminothiazolidine-4-ones

Y. Perumal, Ganesh Samala, J. Sridevi, 2014 .

Investigating structure-activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione [CD59].

P. Yogeeswari, D. Sriram, Shalini Saxena, 2014, International journal of mycobacteriology.

Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.

P. Yogeeswari, D. Sriram, Shalini Saxena, 2015, Tuberculosis.

Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: a study against active, dormant and resistant tuberculosis.

P. Yogeeswari, D. Sriram, V. Soni, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.

P. Yogeeswari, D. Sriram, Shalini Saxena, 2014, European journal of medicinal chemistry.

Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.

P. Yogeeswari, D. Sriram, Shalini Saxena, 2014, Bioorganic & medicinal chemistry.

Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs.

P. Yogeeswari, D. Sriram, P. Kulkarni, 2014, International Journal of Mycobacteriology.

Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling.

P. Yogeeswari, D. Sriram, P. Kulkarni, 2015, Organic & biomolecular chemistry.

Gyrase ATPase Domain as an Antitubercular Drug Discovery Platform: Structure‐Based Design and Lead Optimization of Nitrothiazolyl Carboxamide Analogues

P. Yogeeswari, D. Sriram, P. Kulkarni, 2014, ChemMedChem.

Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leads.

P. Yogeeswari, D. Sriram, P. Kulkarni, 2014, International journal of antimicrobial agents.